Exhibit 23.3

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption "Experts" and to the use of our report dated March 25, 2019, with respect to the consolidated financial statements of AmpliPhi Biosciences Corporation in Amendment No. 1 to the Registration Statement on Form S-1 (No. 333-235656) and related Prospectus of Armata Pharmaceuticals, Inc. for the registration of shares of its common stock.

/s/ Ernst & Young LLP

San Diego, California

January 8, 2020